Changes in eicosapentaenoic acid and docosahexaenoic acid and risk of cardiovascular events and atrial fibrillation: A secondary analysis of the OMEMI trial
2012 ◽
Vol 5
(5)
◽
pp. 978-983
◽
Keyword(s):
2021 ◽
Vol 77
(18)
◽
pp. 229
2021 ◽
Vol 77
(18)
◽
pp. 1453
1994 ◽
Vol 41
(1)
◽
pp. 23-27
◽
Keyword(s):
Keyword(s):